Specialty Pharmacy

Biomarker can help determine the most effective treatment for patients with multiple myeloma.

Dendritic cell-based therapy shows promise treating diabetic peripheral neuropathy and ulcerations in the cornea and skin.

Top news of the day from across the health care landscape.

Subcapsular sinus macrophages may influence cancer mortality.

Antiandrogen therapy plus radiotherapy shows promise reducing prostate cancer mortality.

Borderline personality disorder leads to more risky sexual behavior, increasing the risk of HIV and other sexually transmitted diseases.

Women with HIV are more likely to get pregnant unintentionally.

A high intake of fruit and vegetables in adolescence is linked to a reduced risk of breast cancer, but high alcohol consumption could increase the risk.

Researchers gain greater understanding of genetic and biological basis of diseases such as Alzheimer’s disease, cancer, diabetes, and rheumatoid arthritis.

As melatonin levels rise, beta cells are prompted to release less insulin.

Aerosolized SERCA2a gene shown to stop pulmonary hypertension in swine.

Recent advances and updates in oncology and cancer drug development.

Patients can receive real-time personalized feedback, while providers receive alerts when treatment thresholds are crossed or changes are made.

A repository of biopsy tissue was created from patients with leukemia and lymphoma.

Patients receiving same-day treatment for HIV were more likely to start antiretroviral therapy and had better viral suppression.

Patients administered mitoxantrone for multiple sclerosis carry higher rates of breast and colorectal cancers and leukemia.

The United States accounts about 40% of the global pharmaceutical market.

Top articles of the week on Specialty Pharmacy Times.

Hepatitis C treatment administered in a community-based setting proven to be safe and effective.

Active surveillance seems to be safe in patients who are low risk, and certain patients at intermediate risk.

Top news from across the health care landscape.

Psoriatic Arthritis Impact of Disease test can be administered via a touch screen.

HCV-related death reached 19,596 in 2014 as cases of new infections have more than doubled from 2010 to 2014.

Testosterone therapy may actually inhibit the growth of aggressive prostate cancer.

Paclical/Apealea found to be non-inferior to current treatment for patients with epithelial ovarian cancer.

Grant E. Knowles, vice president of business development at Ardon Health, discusses how biosimilars may impact the high cost of specialty drugs.

Study evaluates survival in older patients with soft tissue sarcoma.

Drug produced by medicinal plant Oldenlandia affinis may block the progression of multiple sclerosis.